CAS: 88040-23-7; 7-(2-(2-Aminothiazol-4-yl)-2-(Methoxyimino)Acetamido)-3-((1-Methylpyrrolidin-1-Ium-1-yl)Methyl)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylate

该化合物是一种广泛频谱的脑膜结膜抗生素,被归类为第四代脑膜结膜松除剂,主要用于治疗各种细菌感染,特别是由古老阴性细菌,包括肺膜炎菌引起的感染.Cefepime通过抑制细菌细胞壁合成,导致细胞分解和死亡而进行工作.它的化学结构特征是乙状乳腺环,这是其抗菌活动必不可少的.它一般通过静脉注射或肌肉内施用,并因其对某些乙状乳腺具有稳定性而闻名,使其对抗抗菌菌菌株有效.该药物一般是经过良好调适的,但潜在的副作用可能包括过敏反应,胃肠紊乱和肾功能的改变.由于它的广谱性活动,cefepime常常保留给严重感染或多抗药性生物体引起的疾病.它的药理学系结合涉及肾上分泌的...

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号88040-25-9 δ2-头孢吡肟酯

合成工艺路线路线简述

  • 71445-20-0 + 103121-85-3 = 88040-23-7
    反应条件:1.1 Reagents: Sodium Bicarbonate Solvents: Dimethylformamide,Water1.2 Reagents: Sulfuric Acid
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    109883-95-6 = 88040-23-7
    反应条件:1.1 Reagents: Formic Acid,Hydrochloric Acid Solvents: Acetone2.1 Reagents: Sodium Bicarbonate Solvents: Dimethylformamide,Water2.2 Reagents: Sulfuric Acid
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    120-94-5 + 109883-98-9 = 88040-23-7
    反应条件:1.1 Solvents: Carbon Tetrachloride2.1 Reagents: Formic Acid,Hydrochloric Acid Solvents: Acetone3.1 Reagents: Sodium Bicarbonate Solvents: Dimethylformamide,Water3.2 Reagents: Sulfuric Acid
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    109883-94-5 = 88040-23-7
    反应条件:1.1 Reagents: Sodium Iodide Solvents: Carbon Tetrachloride,Acetone2.1 Solvents: Carbon Tetrachloride3.1 Reagents: Formic Acid,Hydrochloric Acid Solvents: Acetone4.1 Reagents: Sodium Bicarbonate Solvents: Dimethylformamide,Water4.2 Reagents: Sulfuric Acid
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    79349-53-4 + 100-52-7 = 88040-23-7
    反应条件:1.1 Reagents: Sodium Hydroxide Solvents: Ethyl Acetate,Water1.2 -2.1 Reagents: Sodium Iodide Solvents: Carbon Tetrachloride,Acetone3.1 Solvents: Carbon Tetrachloride4.1 Reagents: Formic Acid,Hydrochloric Acid Solvents: Acetone5.1 Reagents: Sodium Bicarbonate Solvents: Dimethylformamide,Water5.2 Reagents: Sulfuric Acid
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    = 88040-23-7 + 88040-25-9
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Trifluoroacetic Acid2.1 Reagents: Sodium 2-Ethylhexanoate Solvents: Methanol,Ethyl Acetate
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    80756-85-0 + 103121-85-3 = 88040-23-7
    反应条件:1.1 Reagents: Triethylamine Solvents: Ethanol,Water; 0 - 5 °C1.2 2 H,0 - 5 °C1.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1.5
    标题:A Novel Synthetic Route Of 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-Thiazolyl)-2-(Methoxyimino)Acetyl]Amino]-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-3-Yl]Methyl]-1-Methylpyrrolidinium Inner Salt (Cefepime)
    作者:Yu,Pei; Et Al
    参考文献:Zhongguo Kangshengsu Zazhi 日期:2007 卷标:32(12) 页码:751-753]

    885026-53-9 = 88040-23-7
    反应条件:1.1 Reagents: Pyridine,Phosphorus Pentachloride Solvents: Dichloromethane; Rt -> 0 °C; 0 °C; 0 °C -> -10 °C; -10 °C; 1 H,-10 °C1.2 Solvents: Methanol,Phenol; -10 °C; 3 - 5 H,-10 °C1.3 Reagents: Ammonium Hydroxide Solvents: Water; Ph 2 - 2.52.1 Reagents: Triethylamine Solvents: Ethanol,Water; 0 - 5 °C2.2 2 H,0 - 5 °C2.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1.5
    标题:A Novel Synthetic Route Of 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-Thiazolyl)-2-(Methoxyimino)Acetyl]Amino]-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-3-Yl]Methyl]-1-Methylpyrrolidinium Inner Salt (Cefepime)
    作者:Yu,Pei; Et Al
    参考文献:Zhongguo Kangshengsu Zazhi 日期:2007 卷标:32(12) 页码:751-753]

    104146-10-3 + 872-50-4 = 88040-23-7
    反应条件:1.1 Reagents: Potassium Iodide Solvents: Acetone; 3 H,Rt1.2 Solvents: Dichloromethane; -10 °C; 1 H,-10 °C1.3 Reagents: Diisopropyl Ether2.1 Reagents: Pyridine,Phosphorus Pentachloride Solvents: Dichloromethane; Rt -> 0 °C; 0 °C; 0 °C -> -10 °C; -10 °C; 1 H,-10 °C2.2 Solvents: Methanol,Phenol; -10 °C; 3 - 5 H,-10 °C2.3 Reagents: Ammonium Hydroxide Solvents: Water; Ph 2 - 2.53.1 Reagents: Triethylamine Solvents: Ethanol,Water; 0 - 5 °C3.2 2 H,0 - 5 °C3.3 Reagents: Hydrochloric Acid Solvents: Water; Ph 1.5
    标题:A Novel Synthetic Route Of 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-Thiazolyl)-2-(Methoxyimino)Acetyl]Amino]-2-Carboxy-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-3-Yl]Methyl]-1-Methylpyrrolidinium Inner Salt (Cefepime)
    作者:Yu,Pei; Et Al
    参考文献:Zhongguo Kangshengsu Zazhi 日期:2007 卷标:32(12) 页码:751-753]

    88040-23-7 + 72-14-0 = 88040-23-7 + 72-14-0
    反应条件:1.1 Reagents: Cupric Chloride Solvents: Methanol,Water; 12 H,Rt
    标题:Synthesis And Antibacterial Activity Of Copper(Ii) Complexes With Sulphathiazole And Cephalosporin Ligands
    作者:Anacona,Juan R.; Et Al
    参考文献:Transition Metal Chemistry (Dordrecht 日期:2008 卷标:33(4) 页码:517-521]

    14477-72-6 + 88376-58-3 = 88040-23-7 + 112258-91-0
    反应条件:1.1 Solvents: Methanol1.2 Reagents: Sodium 2-Ethylhexanoate Solvents: Ethyl Acetate
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    14477-72-6 + 88376-58-3 + 112258-89-6 = 88040-23-7 + 88040-25-9
    反应条件:1.1 Reagents: Sodium 2-Ethylhexanoate Solvents: Methanol,Ethyl Acetate
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    = 88040-23-7 + 112258-91-0
    反应条件:1.1 Reagents: Trifluoroacetic Acid Solvents: Trifluoroacetic Acid2.1 Solvents: Methanol2.2 Reagents: Sodium 2-Ethylhexanoate Solvents: Ethyl Acetate
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107]

    = 88040-23-7 + 112258-91-0
    反应条件:1.1 Reagents: Acetyl Chloride,Potassium Iodide Solvents: Acetone2.1 Reagents: Trifluoroacetic Acid Solvents: Trifluoroacetic Acid3.1 Solvents: Methanol3.2 Reagents: Sodium 2-Ethylhexanoate Solvents: Ethyl Acetate
    标题:Synthesis And Structure-Activity Relationships Of A New Series Of Cephalosporins,Bmy-28142 And Related Compounds
    作者:Naito,Takayuki; Et Al
    参考文献:Journal Of Antibiotics 日期:1986 卷标:39(8) 页码:1092-107
Benzhydryl (6R,7R)-7-[[(2Z)-2-Methoxyimino-2-[2-(Tritylamino)-1,3-Thiazol-4-Yl]Acetyl]Amino]-3-[(1-Methylpyrrolidin-1-Ium-1-yl)Methyl]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]oct-2-Ene-2-Carboxylate;Iodide 反应生成 头孢吡肟
参考文献:Looker,B. E.
标题:Looker,B. E.

海关参考信息

专利信息


专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-2024197774-A1
优先权日:2021-04-16
标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
权利人:UNIV TEXAS
摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

专利号:US-7592447-B2
优先权日:2003-12-23
标题:Process for production of intermediates for use in cefalosporin synthesis
发明人:LUDESCHER JOHANNES; STURM HUBERT; VORNDRAN KATJA
权利人:SANDOZ AG
摘要:A process for the production of intermediates having a formula IA n nthat can be used for the synthesis of cephalosporins, such as cefepime of formula V. The intermediates of formula IA are produced by desilyation of a compound of formula IIn n nwherein R4 is a silyl-protecting group, with a protic solvent to obtain a compound of formula III,n n nand reacting the compound of formula III with an organic base of formula IVn n nwherein R2 and R3 together represent a C4-alkylene group, and with the adjacent nitrogen atom form a saturated 5-membered heterocycle, and R1 represents a methyl group, to obtain the compound of formula 1A.

专利号:US-10899773-B2
优先权日:2014-12-19
标 题 :Total synthesis of trioxacarcin DC-45-A2 and preparation of trioxacarcin analogs
发明人:NICOLAOU KYRIACOS C; CAI QUAN
权利人:UNIV RICE WILLIAM M
摘要:In one aspect, the present invention provides novel derivatives of trioxacarin analogs of the formula (I) wherein the variables are as defined herein. The application also provides compositions, methods of treatment, and methods of synthesis thereof.

专利号:US-8557979-B2
优先权日:2004-06-10
标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
发明人:CHOI WOO-BAEG; KOWALIK EWA
权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

专利号:US-2016185745-A1
优先权日:2013-08-07
标题:Analogs of vinaxanthone and xanthofulvin, methods of synthesis, and methods of treatments thereof
发明人:SIEGEL DIONICIO; CHIN MATTHEW; ELIASEN ANDERS; AXELROD ABRAM
权利人:UNIV TEXAS
摘要:The present invention relates generally to methods of synthesis of vinaxanthone and xanthofulvin, novel analogs, and methods of use thereof.
宁波人健药业集团股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.rjpharm.com
电话: 86-0574-63976058👤
📞宁波人健药业集团股份有限公司 ⚠️参考联系方式

销售电话:86-0574-63976058
邮箱:info@rjpharm.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
北京嘉瑞时代科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jarytimes.com
电话: 010-58236920 13426038769👤
📞北京嘉瑞时代科技有限公司 ⚠️参考联系方式

销售电话:010-58236920 13426038769
邮箱:askmryu@126.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
海宁凤鸣叶绿素有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.fengming.com
电话: 86-573-87013227 87533318👤
📞海宁凤鸣叶绿素有限公司 ⚠️参考联系方式

销售电话:86-573-87013227 87533318
邮箱:postmaster@fengming.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
武汉华玖医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.whhjpharm.com
企业联系电话:18120446293👤
📞武汉华玖医药科技有限公司 ⚠️参考联系方式
联系人:汪经理
电话:18120446293
手机:18120446293
传真:027-59220200
邮箱:3504472216@qq.com
通信地址: 武汉市东西湖区泾河办事处陈家岭189号
邮编: 432000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:武汉市东西湖区泾河办事处陈家岭189号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
济南德诚和牧医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jndecheng.com
企业联系电话:0531-62325949 18615171096👤
📞济南德诚和牧医药科技有限公司 ⚠️参考联系方式
联系人:肖经理
电话:0531-62325949 18615171096
手机:18615171096
传真:0531-68658860
邮箱:dcyy@vip.sina.com
通信地址: 山东省济南市高新区留学人员创业园2号楼
邮编: 250100
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东省济南市高新区留学人员创业园2号楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Ajibola O, Aremu TO, Dada SO, Ajibola O, Adeyinka KO, Ajibola A, Oluwole OE. The Trend of Cefepime-Induced Neurotoxicity: A Systematic Review. Cureus. 2023 Jun 26;15(6):e40980. doi: 10.7759/cureus.40980.
2: Jean-Michel V, Homey C, Devos P, Delannoy PY, Boussekey N, Caulier T, Leroy O, Georges H. Continuous Infusion of High Doses of Cefepime in Intensive Care Unit: Assessment of Steady-State Plasma Level and Incidence on Neurotoxicity. Antibiotics (Basel). 2022 Dec 30;12(1):69. doi: 10.3390/antibiotics12010069.
3: Al Kamaly O. Review on Characterization, Properties, and Analytical Methods of Cefepime. Int J Anal Chem. 2022 Jun 29;2022:6909528. doi: 10.1155/2022/6909528.

合成参考文献


参考文献:10.1086/651024
摘要:Yuan Z, Ledesma KR, Singh R, Hou J, Prince RA, Tam VH. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. J Infect Dis. 2010 Mar 15;201(6):889–97. doi: 10.1086/651024.
参考文献:10.3201/eid/1706.100358|10.3201/eid1706.100358
摘要:Akhabue E, Synnestvedt M, Weiner MG, Bilker WB, Lautenbach E. Cefepime-ResistantPseudomonas aeruginosa. Emerg. Infect. Dis. 2011 Jun;17(6):1037–43. doi: 10.3201/eid/1706.100358.
参考文献:10.1186/1756-0500-4-236
摘要:Marinho DS, Huf G, Ferreira BL, Castro H, Rodrigues CR, de Sousa VP, Cabral LM. The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital. BMC Res Notes. 2011 Jul 15;4():236.
参考文献:10.1007/s12094-011-0683-0
摘要:Isla D, González-Rojas N, Nieves D, Brosa M, Finnern HW. Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel. Clinical and Translational Oncology. 2011 Jul 31;13(7):460. doi: 10.1007/s12094-011-0683-0.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知